Anju Software announced that Gustave Roussy, one of the top five cancer research centers in the world and Europe's top-ranked hospital for oncology research, has...
R-Pharm Group, the Russian Direct Investment Fund (RDIF) and AstraZeneca announce preliminary virus neutralizing activity results of combined use of the AstraZeneca vaccine (developed...
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.
In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year efficacy study of the Russian...
Sanofi and GSK started enrollment in their Phase 3 clinical study to assess the safety, efficacy, and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine...